Abstract:Dysregulated lipid metabolism promotes the progression of various cancer types, including breast cancer. The present study aimed to explore the lipidomic profiles of patients with breast cancer, providing insights into the correlation between lipid compositions and tumor subtypes characterized by hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status. Briefly, 30 patients with breast cancer were categorized into four groups based on their HR and HER2 status: HR+ no HER2 expression (HER2‐0), HR+ HER2‐low; HR+ HER2‐positive (pos) and HR‐ HER2‐pos. The lipidomic profiles of these patients were analyzed using high‐throughput liquid chromatography‐mass spectrometry. The data were processed through principal component analysis (PCA), partial least squares‐discriminant analysis (PLS‐DA) and random forest (RF) classification to assess the lipidomic variations and significant lipid features among these groups. The profiles of the lipids, particularly triglycerides (TG) such as TG(16:0‐18:1‐18:1)+NH4, were significantly different across the groups. PCA and PLS‐DA identified unique lipid profiles in the HR+ HER2‐pos and HR+ HER2‐0 groups, while RF highlighted phosphatidylinositol‐3,4,5‐trisphosphate(21:2)+NH4 as a crucial lipid feature for accurate patient grouping. Advanced statistical analysis showed significant correlations between lipid carbon chain length and the number of double bonds within the classifications, providing insights into the role of structural lipid properties in tumor biology. Additionally, a clustering heatmap and network analysis indicated significant lipid‐lipid interactions. Pathway enrichment analysis showed critical biological pathways, such as the 'Assembly of active LPL and LIPC lipase complexes', which has high enrichment ratio and statistical significance. In conclusion, the present study underscored that lipidomic profiling is crucial in understanding the metabolic alterations associated with different breast cancer subtypes. These findings highlighted specific lipid features and interactions that may serve as potential biomarkers for breast cancer classification and target pathways for therapeutic intervention. Furthermore, advanced lipidomic analyses can be integrated to decipher complex biological data, offering a foundation for further research into the role of lipid metabolism in cancer progression.

The association between serum lipid levels and histological type of breast cancer

Association of Serum Lipid Levels and Clinical Outcomes in Early Breast Cancer Patients

The Correlation Between Blood Lipids and Clinicopathological Features of Breast Cancer in Young Females.

Exploring lipidomic profiles and their correlation with hormone receptor and HER2 status in breast cancer

The Association Between Blood Lipid And Breast Cancer Risk: Evidence Based On A Dose-Response Meta-Analysis Comprising 900,669 Participants.

Comprehensive Serum Lipidomic Analyses Reveal Potential Biomarkers for Malignant Breast Cancer: A Case-Control Study.

Apolipoprotein C1 (APOC1), A Candidate Diagnostic Serum Biomarker for Breast Cancer Identified by Serum Proteomics Study

The Function and Mechanism of Lipid Molecules and Their Roles in The Diagnosis and Prognosis of Breast Cancer

Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers

Research of the Correlation between Lipid Metabolic and Endometrial Cancer

Association of Hormone-Related Characteristics and Breast Cancer Risk by Estrogen Receptor/progesterone Receptor Status in the Shanghai Breast Cancer Study.

Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: a Multicenter Study in China.

Serum copper and zinc levels in breast cancer: A meta-analysis

Cholesterol: A Predictor of Risk and Prognosis of Breast Cancer

Combination of Endogenous Estradiol and Adipokine Leptin in Breast Cancer Risk and Prognosis Assessment in Postmenopausal Chinese Women

Lipoprotein and metabolite associations to breast cancer risk in the HUNT2 study

Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast Cancer

Evaluation of ER-α, ER-β1 and ER-β2 Expression and Correlation with Clinicopathologic Factors in Invasive Luminal Subtype Breast Cancers

Serum lipid ratios as novel prognostic biomarkers for patients with locally advanced breast cancer treated with neoadjuvant therapy

Progress in the Study of the Correlation Between Apolipoproteins and Endometrial Cancer

[The Study of Associations Between Circulating Tumor Cells and Clinicopathologic Characteristics in Axillary Lymph Node Positive Primary Breast Cancer].